1. Home
  2. JVA vs LEXX Comparison

JVA vs LEXX Comparison

Compare JVA & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$4.71

Market Cap

17.8M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.71

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
LEXX
Founded
1971
2004
Country
United States
Canada
Employees
N/A
7
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
16.2M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
JVA
LEXX
Price
$4.71
$0.71
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
53.3K
197.0K
Earning Date
06-12-2026
04-13-2026
Dividend Yield
1.71%
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
$16.41
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.93
$0.46
52 Week High
$5.62
$1.55

Technical Indicators

Market Signals
Indicator
JVA
LEXX
Relative Strength Index (RSI) 61.27 38.72
Support Level $4.02 $0.62
Resistance Level $4.79 $0.85
Average True Range (ATR) 0.23 0.10
MACD -0.01 -0.04
Stochastic Oscillator 57.60 34.79

Price Performance

Historical Comparison
JVA
LEXX

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: